Smart Insulin Pens are Associated with Improved Clinical Outcomes at Lower Cost Versus Standard-of-Care Treatment of Type 1 Diabetes in Sweden: A Cost-Effectiveness Analysis
Real-world evidence has demonstrated improved glycemic control and insulin management following introduction of smart insulin pens in a Swedish type 1 diabetes (T1D) population. To understand the implications for healthcare costs and expected health outcomes, this analysis evaluated the long-term co...
Shranjeno v:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | angleščina |
| Izdano: |
2020
|
| Online dostop: | https://doi.org/10.1007/s13300-020-00980-1 https://link.springer.com/content/pdf/10.1007/s13300-020-00980-1.pdf |
| Oznake: |
Označite
Brez oznak, prvi označite!
|
Komentirajte kot prvi!